Skip to main content

For urgent surgical problems, please contact the nearest hospital emergency department.

Gangrene

Typical recovery: Recovery depends on the cause and extent of tissue loss. Stable dry gangrene may be managed over days to weeks while vascular assessment and treatment are planned. Wet or infected gangrene requires urgent treatment and hospital recovery depends on infection severity and the operation required. A minor amputation may heal over several weeks if perfusion is adequate, while major amputation requires a longer period of wound healing, physiotherapy and rehabilitation. Revascularisation can also add a separate recovery period.

Key points

  • Gangrene means tissue death and is a sign of serious underlying disease rather than a diagnosis that explains the cause by itself.
  • Dry gangrene is usually caused by severe ischaemia and may remain relatively stable without active infection.
  • Wet gangrene combines tissue necrosis with infection or marked tissue breakdown and requires urgent treatment.
  • Dry black tissue does not automatically mean the limb is infected.
  • Wet gangrene, spreading infection or systemic toxicity should not be managed by waiting for the tissue to demarcate.
  • Severe pain out of proportion, rapid progression, bullae, crepitus and systemic deterioration raise concern for necrotising soft-tissue infection.
  • Necrotising infection is a surgical emergency and treatment should not be delayed for imaging when suspicion is high.
  • In diabetes-related foot infection, extensive gangrene is an indication for urgent surgical consultation.
  • When gangrene occurs with peripheral arterial disease and infection, surgical and vascular specialists should coordinate drainage, debridement and revascularisation decisions.
  • Revascularisation can improve healing potential and may allow a more distal, function-preserving amputation in selected patients.
  • Amputation should remove non-viable tissue at a level that has a realistic chance of healing; the smallest possible operation is not always the safest operation.
  • Major amputation is not inevitable in every patient with gangrene.
  • A black toe with good systemic condition still requires vascular assessment because untreated ischaemia can progress.
  • Antibiotics do not restore blood flow and cannot cure ischaemic dry gangrene.
  • Antibiotics are important when infection is present but cannot replace surgical source control for infected necrotic tissue or abscess.
  • Diabetic neuropathy can make severe tissue damage surprisingly painless.
  • Smoking, diabetes, renal disease and peripheral arterial disease increase the risk of tissue loss and poor healing.
  • After treatment, long-term vascular risk reduction and foot protection are essential to reduce recurrence.

Overview

Gangrene means death of body tissue. In the limbs it most often occurs because blood supply has become critically inadequate, because severe infection has destroyed tissue, or because both processes are present together. The terms dry gangrene and wet gangrene are clinically useful because they describe very different levels of urgency and treatment.

Dry gangrene is usually caused by severe arterial insufficiency. The affected toe, foot or other part becomes dry, shrunken and dark or black, with a relatively clear line between dead and viable tissue. Dry gangrene is not automatically infected. If the tissue remains dry and the patient is systemically well, immediate debridement may not be the first step; the priority is to assess arterial perfusion and determine whether blood flow can be restored. Revascularisation, when feasible, may improve healing potential, preserve more of the limb and define the safest level of any later debridement or amputation.

Wet gangrene is different. It refers to necrotic tissue that is swollen, moist or infected and may be associated with pus, blistering, malodour, spreading cellulitis, fever or systemic toxicity. This is a limb-threatening and potentially life-threatening condition. Treatment usually requires urgent resuscitation, broad antimicrobial therapy when infection is present, and prompt surgical source control such as drainage, debridement or amputation of non-viable tissue. When diabetes-related foot infection is complicated by extensive gangrene, severe ischaemia, deep abscess or necrotising infection, current IWGDF/IDSA guidance recommends urgent surgical assessment; when peripheral arterial disease and infection coexist, vascular and surgical input should be coordinated urgently.

Gas-forming infection or necrotising soft-tissue infection is an emergency. Severe pain, rapidly progressive swelling, crepitus, bullae, dusky skin, tissue necrosis or systemic deterioration should prompt immediate surgical evaluation. Imaging can support diagnosis in selected uncertain cases, but treatment should not be delayed when clinical suspicion of a necrotising infection is high.

The cause of gangrene must be defined. In the lower limb this commonly includes peripheral arterial disease, diabetes, thrombosis or embolism, infection, trauma and pressure-related tissue injury. Assessment therefore includes the extent of tissue loss, presence of infection, pulses and perfusion, neuropathy, renal and cardiac risk, glycaemic control, and whether the limb can realistically be salvaged. Toe pressure, ankle-brachial index, Doppler waveforms, duplex ultrasound, CT angiography or another vascular study may be used according to the clinical situation.

Amputation is sometimes necessary, but the operation should be tailored to the minimum level that will reliably remove non-viable tissue and heal. A minor toe or forefoot amputation may be possible when disease is limited and perfusion is adequate, while more proximal amputation may be required when tissue loss, infection or ischaemia is extensive. In selected cases, revascularisation can be performed before or around the time of debridement to maximise limb salvage. Conversely, uncontrolled sepsis, rapidly spreading necrosis or a non-salvageable limb may require urgent amputation before a full elective vascular work-up is complete.

After treatment, recurrence prevention is essential. Smoking cessation, diabetes control, statin and antiplatelet therapy when indicated, protective footwear, off-loading, daily foot inspection and vascular follow-up can reduce the risk of further tissue loss.

Signs & symptoms

  • Black, brown, dark purple or grey discoloration of a toe, foot or other tissue.
  • Dry, shrivelled or mummified tissue in dry ischaemic gangrene.
  • Coldness, numbness or loss of sensation in an affected limb.
  • Rest pain in the foot, especially at night, in severe arterial insufficiency.
  • Non-healing ulcer or wound associated with tissue necrosis.
  • Swelling, moisture, pus or malodour in wet or infected gangrene.
  • Spreading redness or cellulitis around necrotic tissue.
  • Blisters, bullae or skin breakdown.
  • Crepitus or gas in soft tissues in some necrotising infections.
  • Fever, chills, confusion, low blood pressure or other signs of sepsis in severe infection.

How assessment and treatment are planned

  1. 1

    Assess the patient's overall stability and look immediately for sepsis or rapidly progressive necrotising infection.

  2. 2

    Examine the extent of tissue necrosis and determine whether the gangrene is dry and stable or wet/infected.

  3. 3

    Assess limb perfusion using clinical examination and appropriate vascular testing.

  4. 4

    Look for a source of infection, ulcer, abscess, pressure injury, diabetic foot wound or recent trauma.

  5. 5

    Check for neuropathy, diabetes, renal disease, smoking history and other risk factors for poor healing.

  6. 6

    Obtain blood tests and microbiology when infection or systemic illness is suspected.

  7. 7

    Use imaging such as plain radiographs, ultrasound, CT or MRI when it will clarify deeper infection, gas, osteomyelitis or vascular anatomy without delaying urgent treatment.

  8. 8

    Request urgent surgical review for wet gangrene, extensive infected gangrene, necrotising infection, deep abscess, compartment syndrome or severe limb ischaemia.

  9. 9

    Obtain vascular-specialist input urgently when gangrene is associated with peripheral arterial disease and limb salvage may be possible.

  10. 10

    Start appropriate broad antimicrobial therapy promptly when invasive infection is present.

  11. 11

    Drain abscesses and surgically remove infected or non-viable tissue when source control is required.

  12. 12

    Consider revascularisation when restoring blood flow could improve limb salvage or wound healing.

  13. 13

    Avoid unnecessary early removal of stable dry gangrene before vascular assessment when the patient is well and there is no spreading infection.

  14. 14

    Choose the level of amputation, if required, according to the extent of necrosis, infection, perfusion and the likelihood of wound healing.

  15. 15

    After surgery or revascularisation, continue wound care, pressure off-loading, vascular risk reduction and rehabilitation.

Preparation

  • Bring previous vascular reports, Doppler studies, angiograms or revascularisation records if available.
  • Bring recent photographs if the gangrenous area has changed over time.
  • Bring a list of current antibiotics and previous wound-culture results.
  • Tell the team about diabetes, kidney disease, heart disease, smoking and previous vascular procedures.
  • Bring a full medication list, including antiplatelet agents, anticoagulants, statins and diabetes medicines.
  • Do not stop blood thinners without a specific perioperative plan.
  • Tell the clinician about new rest pain, rapidly increasing discoloration, fever or drainage.
  • If surgery is being considered, discuss whether revascularisation is possible before or around the time of debridement or amputation.
  • Ask what level of tissue removal is expected and what factors will determine whether the wound is likely to heal.

Recovery and aftercare

  • Follow wound-care and dressing instructions after debridement or amputation.
  • Keep pressure off the healing area using the advised footwear, device or mobility aid.
  • Attend vascular follow-up after revascularisation or when peripheral arterial disease is present.
  • Take antiplatelet, statin and other vascular-protection medicines when prescribed.
  • Stop smoking because continued smoking substantially increases vascular and wound-healing risk.
  • Maintain diabetes control and regular foot surveillance.
  • Inspect the opposite foot and remaining toes daily if sensation is reduced.
  • Report new redness, discharge, increasing pain, fever or recurrent black discoloration promptly.
  • Participate in physiotherapy and rehabilitation after amputation to preserve mobility and independence.
  • Use properly fitted footwear and podiatry/foot-care support to reduce recurrent pressure injury.

Risks and possible complications

  • Progression of tissue necrosis.
  • Cellulitis and abscess formation.
  • Necrotising soft-tissue infection.
  • Osteomyelitis.
  • Sepsis and organ failure.
  • Need for repeated debridement.
  • Minor toe or forefoot amputation.
  • Major lower-limb amputation.
  • Poor wound healing because of inadequate perfusion.
  • Failure of revascularisation or restenosis.
  • Recurrent ulceration or gangrene.
  • Chronic pain or phantom-limb pain after amputation.
  • Loss of mobility and independence.
  • Cardiovascular events associated with underlying peripheral arterial disease.

When to seek medical care

  • URGENT: Any new black or rapidly darkening toe, foot or skin area.
  • URGENT: Gangrene associated with increasing redness, swelling, pus or malodour.
  • URGENT: Severe rest pain or sudden worsening of foot pain.
  • URGENT: Cold, pale or numb foot with absent pulses or sudden loss of function.
  • URGENT: Fever, confusion, low blood pressure or other signs of sepsis.
  • EMERGENCY: Rapidly spreading tissue necrosis, severe pain out of proportion, bullae or crepitus.
  • EMERGENCY: Wet gangrene with systemic toxicity.
  • EMERGENCY: Suspected acute limb ischaemia with sudden pain, pallor, pulselessness, sensory loss or weakness.

Myth vs fact

Frequently asked questions

Sources

Medically reviewed by Dr. Shams Alam Mohammed Tahir, MBBS, MS (General Surgery). Last reviewed 2026-10-11.

WhatsApp